Leading our field into tomorrow

Evanthia Galanis, MD, D.Sc., is a Professor of Oncology and the Sandra J. Schulze Professor of Novel Therapeutics at the Mayo Clinic where she has served as the Chair of the Department of Molecular Medicine and leader of the Virus and Gene Therapy Program of the Mayo Clinic Comprehensive Cancer Center. Dr. Galanis’ clinical, translational and laboratory research focuses on the design of new therapeutic approaches for brain tumors and the development and optimization of innovative virotherapy and immunovirotherapy approaches in the treatment of cancer. A significant impetus for her research has been the translation of laboratory advances into clinical trials of novel therapeutics for cancer patients. She has served as principal investigator in multiple cancer gene therapy and virotherapy trials and has pioneered the first in human testing of oncolytic measles virus derivatives and oncolytic virus infected adipose tissue derived mesenchymal stem cells in patients with solid tumors. Dr. Galanis has also served as principal investigator in multiple phase II/III cooperative group [NCCTG, Alliance for Clinical Trials in Oncology (Alliance)] trials testing novel therapeutics in brain tumors. In addition, she has served as the Chair of the Brain Tumor Committee of the cooperative group Alliance for Clinical Trials in Oncology (2012-2023) leading the development of a broad clinical trial portfolio including innovative trial designs, launching of the first individualized medicine neurooncology trials and implementation of standardized MRI protocols in cooperative group trials. Since 2023, Dr. Galanis is serving as the Alliance for Clinical Trials in Oncology Group Chair and Alliance Foundation President. Dr. Galanis has served as a Consultant for the Food and Drug Administration’s Cellular, Tissue and Gene Therapies Advisory Committee and a Board member for the National Brain Tumor Society (NBTS). She is currently the co-Chair of NCI’s GBM and Brain Metastases Interest Group and President of the Society for Neuro-Oncology. She is an elected member of the American Society for Clinical Investigation and the Association of American Physicians. She has also received multiple honors and awards, including the Victor Levin Award of the Society for Neuro-Oncology and the Mayo Clinic Distinguished Investigator Award.

Shawn Hervey-Jumper, MD, PhD, is a neurosurgeon specializing in the treatment of patients with brain tumors, including low- and high-grade gliomas, meningiomas, brain metastases and neurocutaneous syndromes.

Dr. Hervey-Jumper's research investigates how brain tumors violate important areas of the brain that affect how we move, speak and think. He also explores strategies to promote brain recovery and repair. In addition, he researches ways to map the human brain during surgery with the goal of limiting injury to key functional areas.

He received his medical degree from the Ohio State University College of Medicine. He completed both a residency in neurosurgery and a fellowship in neuro-oncology at the University of Michigan. He then completed a clinical fellowship in neuro-oncology at UCSF.

Dr. Hervey-Jumper currently serves as the Secretary-Treasurer of the Society for Neuro-Oncology.

Adrienne Boire, M.D., Ph.D. is the Geoffrey Beene Junior Faculty Chair at Memorial Sloan Kettering Cancer Center in New York. As a neuro-oncologist, she cares for patients with metastasis to the central nervous system (CNS), with particular focus on leptomeningeal metastasis.  As a scientist, she runs a laboratory-based research program focused on the leptomeningeal space and the metastases that inhabit this interface between the central nervous system and the systemic circulation. Her team employs multi-omic analysis of human samples to capture communication between the brain and the body, and to identify cancer cell adaptations to the challenging microenvironment of the leptomeninges. Leveraging mouse models, in vitro modeling, and classical biochemical techniques, the team uncovers the mechanistic implications of these discoveries to establish novel therapies for the prevention and treatment of leptomengingeal metastasis.

Chas Haynes, JD is the Executive Director of the Society for Neuro-Oncology, a position he has held since 2006.  Mr. Haynes is responsible for the day-to-day operations of SNO, and works with the elected leadership to implement the Society’s strategic plan.  He has over 25 years of experience in the leadership and operational management of non-profit medical associations, including the CERN Foundation, the International Brain Injury Association, and the North American Brain Injury Society.

Mr. Haynes received a Bachelor of Arts degree from the University of Texas, Austin, and a Juris Doctor degree from the South Texas College of Law in Houston, Texas.  He currently serves as an ex officio board member of the Society for Neuro-Oncology and Beat Brain Cancer, the Foundation of the Society for Neuro-Oncology.

Daphne Haas-Kogan, MD, MBA, FACR, FASTRO, is Chair of the Department of Radiation Oncology at Mass General Brigham, Boston Children’s Hospital, The Chief of Enterprise Radiation Oncology, and the Willem and Corrie Hees Family Professor of Radiation Oncology at Harvard Medical School. 

Dr. Haas-Kogan received her undergraduate degree in biochemistry and molecular biology magna cum laude from Harvard University, was elected to Phi Beta Kappa, and was awarded the Thomas T. Hoopes Prize and summa cum laude for her Honors Thesis. While in medical school at UCSF she was an HHMI Medical Fellow and was elected to the Alpha Omega Alpha Medical Honor Society. She completed her residency in radiation oncology at UCSF in 1997. At UCSF she was vice-chair for research from 2003, and educational program director from 2008.  

Dr. Haas-Kogan’s laboratory research focuses on molecular underpinnings of brain tumors and pediatric cancers. She leads large multi-institutional grants (U54, SPORE) funded by NIH/NCI, philanthropic initiatives, and industry collaborations. Dr. Haas-Kogan has been selected as a U.S. top physician, was appointed to the Blue Ribbon Panel of the National Cancer Moonshot Initiative, and was elected to the Association of American Physicians (AAP). Dr. Haas-Kogan was elected to the National Academy of Medicine, Fellow of the American College of Radiology (ACR), and Fellow of The American Society for Radiation Oncology (ASTRO).  She was awarded the highest mentorship recognition at DFCI--The Edward J. Benz, Jr. Award for Advancing the Careers of Women Faculty.  Dr. Haas-Kogan was elected to serve as President of the Society of Neuro-Oncology. In 2025, she was nominated for the Pinnacle Award, honoring business and professional women who have demonstrated excellence in entrepreneurship, management, and lifetime achievement. In December of 2025, she received the Janeway Medal from the American Radium Society. 

Dr. Susan Chang is a Professor in the Division of NeuroOncology and specializes in treating adults with brain tumors. She is a co-leader for the NeuroOncology Program for the Helen Diller Family Comprehensive Cancer Center and a Principal Investigator in the Brain Tumor Center. She has a major research focus on the development of novel therapies for patients and has served as the PI on numerous clinical trials. She is a leader on multi-programmatic grants (including NIH funded SPORE and Program Project Grants) that address the integration of physiologic and metabolic imaging with genomic biomarkers to optimize the management of patients with primary brain tumors. She is also a co-leader for a grant that addresses the interplay of genomic and immune characteristics with external factors that affect health outcomes in patients with meningioma, prostate and breast cancer. 

 Dr. Chang is especially dedicated to improving the experience of her patients and their families, with a particular focus on increasing quality of life. She is the founder, Co-Director and Endowed Professor of the UCSF Neuro-Oncology Gordon Murray Caregiver Program, which provides resources and support to the caregivers of brain tumor patients. She is also the co-Director of the Sheri Sobrato Brain Cancer Survivorship Program focused on comprehensive survivorship care for brain tumor patients.  

 Dr. Chang has served several leadership positions for the Society for NeuroOncology and is the Editor in Chief of NeuroOncology. 

Dr. de la Fuente is the Chief of the Neuro-Oncology Division and Director of the Neuro-Oncology Fellowship Program at the Department of Neurology, University of Miami, and co-Director of the Sylvester Brain Tumor Institute and Chair of the Neuro-Oncology Site Disease Group at Sylvester Comprehensive Cancer Center. In these leadership roles, she oversees both the clinical and clinical research programs in Neuro-Oncology at the University of Miami. 

Dr. de la Fuente is a graduate of the Neuro-Oncology Fellowship program at Memorial Sloan Kettering Cancer Center in New York, where she served as a Consultant in the Department of Neurology after finishing her fellowship. As a clinical trialist and translational researcher, Dr. de la Fuente’s work is dedicated to advancing targeted therapies and biomarkers for primary brain tumors, with the overarching goal of delivering more effective, less toxic, and individualized treatment options. 

Dr. de la Fuente is an active member of the Society for Neuro-Oncology (SNO), where she serves on the Board of Directors as neurology representative. Additionally, she is a Member of the Scientific Advisory Council of the Florida Center for Brain Tumor Research, appointed by the President of the Florida Senate. 

Javier Villanueva-Meyer, MD, is an Associate Professor in the Neuroradiology section in the Department of Radiology and Biomedical Imaging at the University of California, San Francisco. He received his medical degree from Baylor College of Medicine in Houston, Texas, and he completed his one-year internship at Virginia Tech Carilion School of Medicine in Roanoke. Dr. Villanueva-Meyer completed his four-year diagnostic radiology residency at the UCSF, followed by a Neuroradiology fellowship at UCSF. He also completed a NIH T32 post-doctoral fellowship in the UCSF Department of Radiology and Biomedical Imaging.

Dr. Villanueva-Meyer’s interests focus on advanced MR imaging and imaging based tools to better delineate and characterize brain tumors. His research also involves molecular imaging where he works with collaborators within and outside of our department to develop and implement the use of PET radiotracers in both brain tumors and spinal infection.

Dr. Villanueva-Meyer has experience in CT, MRI and plain film radiography of the brain, head and neck, spine, and peripheral nervous system in both the inpatient and outpatient settings. As well as diagnostic and therapeutic neuroradiology procedures, including percutaneous biopsy, lumbar puncture, myelography, cisternography, epidural and selective nerve root injection.

Mariella G. Filbin, MD, PhD, is a Pediatric Neurooncologist and Principal Investigator at Dana-Farber Cancer Institute and Boston Children’s Hospital, and an Associate Professor of Pediatrics at Harvard Medical School. She holds the Jan Paradise Chair in Brain Cancer Research, is the Research Director of the Pediatric Neuro-Oncology Program, and Co-director of the Brain Tumor Center of Excellence at Dana-Farber Cancer Institute and Boston Children’s Hospital.  Dr. Filbin’s research focuses on pediatric brain tumors, particularly high-grade gliomas. In her studies, she is combining single-cell genetics and transcriptomics with gene editing, epigenetic, stem cell, and pharmacologic methods to identify networks underlying tumorigenesis, with the goal of establishing new druggable targets.

Dr. Filbin has been recognized with many honors and awards, including election to the ASCI (American Society for Clinical Investigation), the Mark Foundation Emerging Leader Award, the NIH director's New Innovator award, the Distinguished Scientist Award from the Sontag Foundation, the Trailblazer Award from the Helen Gurley Brown Foundation, awards from the Burroughs Wellcome Fund, Alex’s Lemonade Stand Foundation, National Cancer Institute, Broad Institute of MIT and Harvard, and Austrian Academy of Science. She also received teaching awards from Harvard Medical School.

Dr. Filbin also serves as the Pediatric Representative on the Society for Neurooncology (SNO) Board of Directors, Steering Committee member of the Pediatric Cancer Working group for the American Association of Cancer Researchers (AACR), Co-chair of the High-grade glioma working group of PBTC,  Scientific Committee of the Pacific Neuro-Oncology Consortium (PNOC) and the High Grade Glioma working group for both the Collaborative Network for Neuro-oncology Clinical Trials (CONNECT) and the Children’s Oncology Group (COG).  She is also on the Scientific Medical Advisory Council Member for the National Brain Tumor Society (NBTS). 

Dr. Filbin completed her Doctor of Medicine and Doctor of Philosophy in Graz, Austria, before completing her Pediatrics residency at Boston Children’s Hospital, and her subspecialty fellowship training in Pediatric Hematology/Oncology at Dana-Farber/Boston Children’s Cancer and Blood Disorder Center. She trained in the laboratories of Rosalind Segal, MD, PhD, at Dana-Farber Cancer Institute; Todd Golub, MD, at Dana-Farber Cancer Institute and the Broad Institute; and Mario Suva, MD, PhD, at Massachusetts General Hospital. Dr. Filbin established her own laboratory at Dana-Farber Cancer Institute in 2018.

Ashlee Loughan, PhD, is a clinical neuropsychologist and Associate Professor in the VCU School of Medicine’s Department of Neurosurgery, Division of Neuro-Oncology. She is also an Associate Member of the Cancer Prevention and Control Program at Massey Comprehensive Cancer Center and Director of the LiveNOW (Neuro-Oncology-Wellness) Laboratory. Her clinical and research work focuses on developing and delivering evidence-based neuropsychological care for individuals with brain tumors and their families, with particular emphasis on the cognitive, emotional, and behavioral challenges that often follow aggressive brain tumor diagnoses, including cognitive impairment, existential distress, and insomnia. Dr. Loughan’s research has been supported by institutional funding from VCU and Massey, as well as foundation and federal sources, including the National Brain Tumor Society, American Psychological Foundation, the National Cancer Institute, the Department of Defense, and NRG Oncology. She holds leadership roles in several national and international organizations, serving as an elected Board Member of the Society for Neuro-Oncology, Chair of the Clinical Advisory Board for the American Brain Tumor Association, Founder and Co-Chair of the RANO Cognitive Outcomes Working Group, and Co-Chair of the RANO Patient-Reported Outcomes Working Group. She is also an active member of NRG Oncology and the Alliance for Clinical Trials in Oncology, where she serves as Neuro-Oncology Patient-Reported Outcomes Chair across multi-site trials. Grounded in the experiences of patients and caregivers, Dr. Loughan maintains a weekly clinical practice at VCUHealth while advancing national research initiatives through LiveNOW. Her work aims to expand patient-centered neuro-oncology care and improve outcomes across clinical settings nationwide.

Megan M. Bell-Johnston serves as the Sponsorship Fulfillment & Exhibit Logistics Specialist at the Society for Neuro-Oncology. In this role, she oversees the successful execution of sponsorship deliverables and manages all aspects of exhibit logistics for the Society’s meetings and events.

Following the finalization of partnership agreements, Megan acts as the primary point of contact for industry partners, exhibitors, the exposition company, and internal teams, ensuring seamless coordination, accurate fulfillment of commitments, and a high level of partner satisfaction.

With more than 13 years at the Society, Megan has also contributed to event operations in areas such as food and beverage coordination and the Annual Conference gala. She holds a Bachelor of Science in Materials Science and Engineering, as well as a Certification in Exhibit Management.

Maloree Burgin is a dynamic event and sponsorship professional with a passion for creating meaningful, high-impact experiences that bring people together. As Manager of Sponsorship and Event Planning for the Society for Neuro-Oncology (SNO), she leads strategic partnerships and engagement opportunities that support the advancement of education, research, and collaboration within the neuro-oncology community.

Known for her relationship-driven approach, Maloree works closely with industry partners and supporters to develop tailored sponsorship opportunities that align organizational goals with mission-driven impact. She plays a key role in planning and executing SNO’s premier meetings, including the SNO Annual Meeting, SNO Pediatric Meeting, and the SNO/ASCO CNS Metastases Meeting, ensuring a seamless and engaging experience for all participants.

Maloree is also the creative force behind SNO’s signature social events - from the Welcome Reception and Poster Reception to the Annual Gala, bringing energy, thoughtful detail, and a touch of fun to every experience. She is passionate about designing environments that spark connection, celebration, and lasting impressions.

With a strong background in event planning, project management, and partner engagement, Maloree brings a positive, solutions-oriented mindset and a warm, approachable style to her work. She is dedicated to building lasting relationships and delivering exceptional experiences that elevate both partners and the broader scientific community.

Stacy Flach is a Registered Nurse and Certified Pediatric Nurse who serves as a Manager of Medical Education for SNO. She brings a strong clinical and leadership background shaped by diverse experiences across adult and pediatric healthcare settings. Stacy spent seven years as a clinical nurse in the Brain and Spine Clinic at MD Anderson Cancer Center before transitioning into pediatric nursing at Texas Children’s Hospital.  

Most recently, Stacy held a leadership role within the Orthopedic, Rehabilitation, and Pain Management outpatient clinics at Children’s Hospital Colorado, where she supported teams across multiple sites in delivering high-quality, patient-centered care. 

Originally from Texas, Stacy has lived in both the Dallas and Houston areas before relocating to Highlands Ranch, Colorado, where she resides with her husband and two children. In her free time, she can often be found cheering on her sons at the hockey rink and baseball field. 

Stacy has always been driven by a passion for helping others through both her professional work and volunteer efforts. She remains committed to supporting colleagues, patients, and families, and is grateful to continue making a meaningful impact in her career. 

Gabrielle Griffin is the Marketing and Communications Manager for the Society for Neuro-Oncology. In her role, Gabby leads marketing strategy for conferences and events and manages multi-channel communications including the SNO Digest, social media, and web content. 

Originally from New Orleans, Louisiana, Gabby now resides in the Houston area where she enjoys spending time with her family and friends, exploring new restaurants, and hanging out with her dog, Zara. 

Chas Haynes, JD is the Executive Director of the Society for Neuro-Oncology, a position he has held since 2006.  Mr. Haynes is responsible for the day-to-day operations of SNO, and works with the elected leadership to implement the Society’s strategic plan.  He has over 25 years of experience in the leadership and operational management of non-profit medical associations, including the CERN Foundation, the International Brain Injury Association, and the North American Brain Injury Society.

Mr. Haynes received a Bachelor of Arts degree from the University of Texas, Austin, and a Juris Doctor degree from the South Texas College of Law in Houston, Texas.  He currently serves as an ex officio board member of the Society for Neuro-Oncology and Beat Brain Cancer, the Foundation of the Society for Neuro-Oncology.

Amelia Hutsell is SNO’s Administrative Specialist. In her role, she manages accounts payable and receivable, ensuring accurate and timely financial processes, and supports grant proposal preparation and submission. She also coordinates key programs and special projects, including the Editorial Scholars and Editorial Fellows Programs. Additionally, she provides behind-the-scenes support for events, member services, and daily operations by assisting with a range of logistical, administrative, and programmatic tasks to ensure everything runs smoothly and efficiently. 

Alongside her professional work, Amelia is pursuing a Master of Public Health (MPH) with a concentration in Applied Epidemiology at the University of North Carolina at Chapel Hill where she is focusing on developing her skills in data analysis, disease surveillance, and population health research. She has a particular interest in cancer epidemiology. 

Amelia currently resides in her hometown of Asheville, NC, where she enjoys the peaceful mountain scenery, exploring local coffee shops, and hanging out with friends and family.  

Shelley Hwang, MBA, CMP, HMCC, is a seasoned nonprofit leader with more than 20 years of experience in administration, event strategy, and partnership development. As Director of Administration for the Society for Neuro-Oncology (SNO), she leads cross-functional operations, including marketing and communications, exhibit and support management, program development, and large-scale meeting and event execution. She plays a key role in advancing SNO’s mission by driving operational excellence, strengthening stakeholder engagement, and supporting high-impact educational and scientific initiatives.

Shelley is recognized for her ability to build collaborative relationships across multidisciplinary communities and to implement efficient systems that enhance organizational performance. Prior to SNO, she held leadership roles at the Pediatric Brain Tumor Foundation, where she oversaw mission-driven programs, including family support services and scholarship initiatives.

She holds an MBA and dual bachelor’s degrees in political science and social science, and is a Certified Meeting Professional (CMP) with a Healthcare Meeting Compliance Certificate (HMCC).

Olivia is the eLearning and Instructional Technology Specialist here at SNO. She manages the SNO’s learning academy and runs SNO’s educational webinars. Olivia works together with SNO leadership and staff to bring quality education and content to all in the virtual space.  

Olivia is a native Chicagoan and can be found enjoying all that the chicagoland area has to offer with her family and friends. She especially enjoys frequenting local coffee shops and bookstores. 

As a Medical Education Manager with the Society for Neuro-Oncology (SNO), Kris works with multiple committee members and the SNO team to ensure all programmatic aspects of the SNO/ASCO CNS Metastases Conference, Neuro-Oncology Review Course, Clinical Trial Design and Protocol Development Workshop, and the Fellow and Early Clinician/Investigator Career Retreat are well organized and run smoothly. In addition, Kris oversees the travel scholarship program, multiple SNO committees, and abstract management for the SNOSSA Meeting.

Prior to joining SNO, she spent 12 years with the National Brain Tumor Society (NBTS) where she served in leadership roles in Marketing & Communications, Community Relations, and Program Management for Research Initiatives and Partnerships. Her broad array of experience and relationships with all different groups within the brain tumor community allow her to seamlessly navigate opportunities and growth looking ahead at SNO. Her earlier career work focused on marketing efforts for several for-profit businesses after starting her career in the agency world, guiding a diverse array of organizations in strategic branding, marketing, and communications.

Kris lives in Portland, Maine where she serves on two volunteer boards and, together with her family, constantly tries to make the most of all their neighborhood and region have to offer.

Tara Mammoser is a registered nurse and currently serving as the Manager of Medical Education for The Society for Neuro-Oncology. She spent seven years working as a clinic nurse at the University of Texas, MD Anderson Cancer Center in The Brain and Spine Center.  

Tara lives between her hometown New Orleans, LA and Atlanta GA and spends her free time with her husband Aaron and their rescue dog Mina.  

As the CME Manager for the Society for Neuro-Oncology, MeLesa works with the SNO  Leadership and SNO Staff to ensure that all Medical Education is compliant with the ACCME Standards for Integrity and Independence in Accredited Continuing Education. 

 Prior to joining SNO, MeLesa spent 17 years at the University of Texas MD Anderson Cancer Center  in Houston, both as a Neuro-Oncology Research Nurse and as an outpatient clinic nurse. During that time she spent 12 years in the Brain & Spine Department, then 5 years at the League City Outpatient Clinic working with Breast Surgical Oncology and Head & Neck Surgical Oncology. 

MeLesa currently resides in Central Ohio, with her husband and enjoys a variety of outdoor activities.